The main goal of coronary revascularization is to restore myocardial perfusion in case of ischemia, causing coronary artery disease. Yet, little is known on the effect of revascularization on absolute myocardial blood flow (MBF). Therefore, the present prospective study assesses the impact of coronary revascularization on absolute MBF as measured by [
C
oronary revascularization by either percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG) are common treatment strategies for coronary stenosis causing ischemia. Current guidelines justify these strategies as they confer symptomatic and survival benefit in selected patients with stable coronary artery disease (CAD). 1, 2 Several studies have shown that ischemiaguided revascularization improves event-free survival as compared with symptom or angiographic stenosis severity-driven treatment. 3, 4 Invasively measured fractional flow reserve (FFR) is considered the reference standard in determining the functional severity of coronary stenosis to guide revascularization therapy. 3, 5 Myocardial perfusion imaging (MPI) using positron emission tomography (PET), however, is a noninvasive method to assess hemodynamic consequences of CAD and, thereby, identifies patients who may benefit from coronary revascularization. 6, 7 Furthermore, PET enables quantification of myocardial perfusion in terms of absolute myocardial blood flow (MBF). 8, 9 Although both FFR and PET MPI provide information on the functional significance of CAD, there are distinct differences between these 2 physiological parameters. Namely, FFR reflects the pressure gradient over an epicardial coronary artery stenosis, while PET measures the net impact of coronary stenosis, diffuse atherosclerotic disease, and coronary microvasculature. 7, 10, 11 The main goal of coronary revascularization is to improve myocardial perfusion, yet mere alleviation of coronary diameter stenosis may not be accompanied by restoration of perfusion. The extent of post-procedural increase of FFR has been linked to outcome. 12 The postulated mechanism is an agreement between the reduction of the hyperemic pressure gradient across the coronary lesion and enhancement of flow reserve and, thus, reduction of ischemic burden. Comparative studies on the impact of revascularization on FFR in relation to myocardial perfusion are, however, lacking. Furthermore, virtually no data are available on the mode of revascularization (ie, surgical versus percutaneous) to improve MBF. Therefore, the present prospective sub study of the PACIFIC trial (Prospective Comparison of Cardiac PET/CT, SPECT/CT Perfusion Imaging and CT Coronary Angiography With Invasive Coronary Angiography) 13 assesses the impact of coronary revascularization by either CABG or PCI on absolute MBF as measured by [ 15 O]H 2 O PET in patients with stable CAD.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure. The study population consisted of a subset of patients from the PACIFIC trial (NCT01521468), who were prospectively enrolled to undergo [
15 O]H 2 O PET prior to invasive coronary angiography with routine FFR measurements. 13 Enrolled patients were suspected of stable CAD and had a normal left ventricular function. Exclusion criteria were a documented history of CAD, signs of prior myocardial infarction, contraindications to adenosine, atrial fibrillation, glomerular filtration rate <45 mL/min, and pregnancy. For the current analysis, only patients were included who underwent coronary revascularization (PCI or CABG) followed by routine serial PET MPI. No cardiac events were documented between revascularization and follow-up MPI. The study protocol was approved by the Medical Ethics Review Committee of the VU University Medical Center. All patients provided written informed consent.
CLINICAL PERSPECTIVE
In case of ischemia, caused by coronary artery disease, revascularization by means of percutaneous coronary intervention (PCI) or coronary artery bypass graft is primarily intended to restore myocardial perfusion. Pressure measurements with fractional flow reserve are considered the reference standard to determine functional stenosis severity and guide revascularization treatment. Additionally, quantitative myocardial perfusion imaging allows for a noninvasive assessment of myocardial blood flow. With a serial assessment of each of these measures, the quantitative impact of either PCI or coronary artery bypass graft can be determined. The current prospective study shows that successful revascularization results in improved pressure gradients as assessed with fractional flow reserve directly post-PCI, as well as flow parameters derived from myocardial perfusion imaging with positron emission tomography. Interestingly, improvements of fractional flow reserve immediately post-PCI were in close relation with improvements of stress flow and flow reserve. These findings support the postulated mechanism between the prognostically important reduction in pressure gradients and enhancement of flow and, thus, the reduction of ischemic burden. As such, positron emission tomography perfusion imaging could be useful to identify patients who might benefit from revascularization. The presence of traditional cardiovascular risk factors, however, did not evidently predict the degree of myocardial perfusion restoration. In contrast, PCI resulted in a greater improvement in stress myocardial blood flow as compared with coronary artery bypass graft, taking into account that patients who underwent surgical treatment had more severe coronary artery disease.
Positron Emission TomographyComputed Tomography
Patients were instructed to refrain from intake of products containing caffeine or xanthine for 24 hours prior to the scan. All patients were scanned on a PET/computed tomography (CT) device (Philips Gemini TF 64; Philips Healthcare, Best, The Netherlands) with [
15 O]H 2 O as a perfusion tracer during resting conditions and during vasodilator stress using intravenous infusion of adenosine (140 μg/kg/min). The cardiac PET protocol is described in detail previously.
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In addition, patients underwent a CT scan for calcium scoring as previously described.
14 CT scans were analyzed with a 3-dimensional workstation (Brilliance, Philips). All patients underwent the same PET MPI protocol before and after revascularization. Parametric MBF images were generated using in-house developed software, Cardiac VUer. 15 Absolute MBF was calculated for each of three vascular territories (left anterior descending artery, left circumflex artery, and right coronary artery). Coronary flow reserve (CFR) was defined as the ratio between hyperemic and baseline MBF. In case of single-vessel or two-vessel disease, relative flow reserve (RFR) was calculated as the ratio of hyperemic MBF in a stenotic area to hyperemic MBF in a nonstenotic reference vascular territory. 16, 17 Segmental PET analysis was performed using the coronary anatomy obtained from invasive coronary angiography, whereby a perfusion defect of at least 2 adjacent myocardial segments was assigned to one of the vascular territories. Subsequently, this regional perfusion value was used for further analyses instead of the average MBF or CFR of the predefined vascular territory to avoid impact of overlapping adjacent vascular regions.
Invasive Coronary Angiography and FFR
Invasive coronary angiography imaging was performed in at least 2 orthogonal directions per evaluated coronary artery segment. All major coronary arteries were routinely interrogated by FFR, except for occluded or subtotal lesions of >90%. The FFR was measured using a sensor-tipped guidewire (Volcano Corporation, Rancho Cordova, CA), and intracoronary (150 μg) or intravenous (140 µg/kg/min) adenosine infusion was used to induce maximal coronary hyperemia. The FFR was calculated as the ratio of the mean distal intracoronary pressure to the mean arterial pressure. A coronary stenosis with an FFR ≤ 0.80 was considered hemodynamically significant. In case FFR was not performed, a stenosis >90% was also considered functionally relevant. The choice of treatment (ie, PCI, CABG, or optimal medical treatment) was left to the discretion of the operator and the heart team if applicable, taking into account patient characteristics together with angiographic and FFR results. In the event of PCI, post-procedural FFR measurements were performed to assess the direct effect on coronary pressure gradients.
Statistical Analysis
Continuous variables are presented as mean values±standard deviation or median (interquartile range) as appropriate, whereas categorical variables are expressed as frequencies and percentages. Differences between continuous baseline characteristic variables were compared using the 2-sided Student's t test, whereas differences between categorical baseline variables were analyzed by the χ 2 test or Fisher exact test when appropriate. Mixed models with a random effect for subject were used to compare means on pre-and post-measurements. This was done by testing whether the mean of the vessel-specific change-scores differed from 0. Covariates were added to identify predictors of MBF and CFR improvement. These mixed models were used rather than standard linear regression to account for correlation of outcomes between multiple revascularized territories within the same patient. Univariable and multivariable regression coefficients were reported as effect sizes for mixed models. Variables significant at the 0.2 level in the univariable analysis were included in the multivariable model. Evaluation of relationships between FFR and MBF was performed using Pearson's correlation analysis. Correlations were compared using the Fisher r-to-z transformation. A P value <0.05 was considered statistically significant. All statistical analyses were performed using IBM SPSS software package version 20 (IBM SPSS Statistics, IBM Corporation, Armonk, NY).
RESULTS
Baseline characteristics of the study population are listed in Table 1 . In total, 53 patients are described in the current study, mean age was 58.7±9.0 years, and 46 (87%) were men. Of these patients, 66% was revascularized percutaneously, whereas 34% underwent CABG ( Table 2 ). The median interval between PCI or CABG and follow-up PET was 20 days (interquartile range, 10-29 days) and 62 days (interquartile range, 34-92 days), respectively. No cardiac events occurred between revascularization and follow-up MPI.
Change of Absolute Myocardial Perfusion and FFR After Revascularization
Mean baseline flow as assessed with PET in 90 myocardial territories targeted for revascularization during rest was 0.77±0.16 and 1.57±0.59 mL/min/g during hyperemia, yielding a CFR of 2.02±0.69. In remote areas, baseline rest MBF was 0.86±0.21 mL/min/g, stress MBF 2.45±0.73 mL/min/g, and CFR 2.91±0.94 (P<0.01 for all flow parameters as compared with areas targeted for revascularization). The RFR for single-and two-vessel disease revealed to be 0.65±0.18 (n=48 vascular territories). After revascularization, both rest and hyperemic MBF were significantly improved (0.86±0.25 and 2.48±0.91 mL/min/g, respectively, P<0.01 for both), yielding a significantly increased CFR and RFR (2.94±0.94 and 0.98±0.15, respectively, P<0.01 for both; Figure 1) . A decrease of regional stress MBF, however, was observed in 5 (10.6%) percutaneously treated and in 5 (11.6%) surgically treated vessels, which were characterized by a relatively high regional MBF at baseline (mean 2.20±0.82). Likewise, CFR was lower in 9 (19.1%) and 12 (27.9%) vascular territories after PCI and CABG, respectively, also with a rather preserved CFR at baseline (2.54±0.71).
Driessen et al; Revascularization Effects on Myocardial Blood Flow
Among 90 revascularized vessels, 61 (68%) were interrogated by FFR at baseline, with a mean FFR of 0.61±0.17, while other measurements were lacking because of total occlusions (13%) or stenosis severities beyond 90% (19%). FFR was measured directly post-PCI in 30 vessels (64% of vessels treated percutaneously with an FFR measured pre-PCI) and improved toward a mean FFR of 0.89±0.08.
Relationship Between Absolute Myocardial Perfusion and FFR
At baseline, rest MBF did not correlate with FFR: r=0.08 (P=0.41) as depicted in Figure 2A . Baseline hyperemic MBF, CFR, and RFR showed significant correlations with FFR measurements (Figure 2B and 2D ). Among these parameters, RFR, determined only in case of single-or two-vessel disease, revealed the best correlation (r=0.76, P<0.05 compared with hyperemic MBF and CFR). Notably, increases in FFR after PCI paralleled improvement in quantitative myocardial perfusion as reflected by hyperemic MBF, CFR, and RFR (r>0.70 for all, Figure 3 ). Alteration in rest MBF was not correlated with the change in FFR. Taking into account multiple measures per patient, by correlating per-patient mean PET and FFR measurements, showed similar outcomes and significance. Nonetheless, there was no significant relationship for FFR parameters with baseline and delta rest MBF (P=0.13 and P=0.96, respectively.), whereas baseline and delta stress MBF (P<0.01 and 
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Predictors of MBF Improvement
Among various cardiovascular risk factors, smoking at the time of revascularization was the only independent predictor (β=0.85, P=0.028) of improvement in hyperemic MBF (Table 4) . Furthermore, while the presence of diabetes mellitus correlated with restoration of CFR using univariable regression analysis (β=−0.84, P=0.046), it did not remain a predictor using a multivariable analysis (Table 5) .
DISCUSSION
This prospective study provides a comprehensive analysis on the impact of coronary revascularization on restoration of absolute myocardial perfusion. In addition, the current results provide insight into the relationship between the absolute change of FFR and MBF elicited by PCI. The main findings are as follows: (1) 
Functional Assessment of CAD
Clinical management of CAD, including coronary revascularization, is increasingly based on the functional severity of coronary stenosis.
1,2 Especially, the FAME trial (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) has paved the way for FFR measurements for assessing the functional relevance of CAD by showing that angiography-guided revascularizations conferred no prognostic or symptomatic benefit as opposed to FFR-guided revascularizations. 3, 5 As such, FFR is nowadays considered the gold standard for discerning the hemodynamic relevance of coronary artery stenosis. 2 Although FFR is an excellent tool for determining the functional relevance of focal epicardial disease, altered coronary microvascular resistance may affect identification of ischemia by FFR. 18 Although the impact of coronary microvascular disease on myocardial perfusion is disguised by FFR, 19 quantitative PET provides an integrated measurement of the total coronary vascular bed. 7, 10 In this regard, FFR and MPI provide complementary information on coronary vascular health and are not necessarily concordant. As a consequence, the correlation between FFR and quantitative myocardial perfusion in terms of hyperemic MBF and CFR was moderate at best, highlighting the potential physiological discordancy between pressure and flow, which is consistent with previous work. 8, 11, 19 When a correction for global microvascular function was applied, by calculating the ratio of flow in the designated territory to the flow in a territory without epicardial obstructive disease (RFR), the agreement with FFR significantly improved (Figure 2) , corroborating the notion that coronary pressure and flow are not to be assumed interchangeable. These results are in line with previous studies investigating coronary physiology and FFR. 16, 17, 20, 21 
Concordant Improvement of MBF and FFR
There is a paucity of data on the effect of percutaneous intervention on absolute quantitative MBF. 22, 23 In the present study, there was an average increase of resting, hyperemic, and flow reserve of approximately 14%, 65%, and 51%, respectively. Of interest, RFR increased to near normal levels (0.98±0.15), indicating the success of revascularization. From a theoretical point of view, an augmentation of FFR by PCI should be accompanied with ameliorated stress perfusion. Data to substantiate this hypothesis, however, are lacking. In our study population, the absolute change in FFR induced by PCI was in close agreement with enhanced PET-derived stress perfusion measurements, that is, hyperemic MBF, CFR, and RFR (Figure 3) . This concordant improvement of FFR and PET MBF measurements have 2 important implications. First, these findings highlight the fact that restoration of post-PCI FFR is accompanied by normalization of stress perfusion, and the prognostic benefit of an adequate post-PCI FFR (ie, >0.90) is most likely mediated by augmented perfusion rather than pressure. 5, 12, 24 Second, corresponding restoration of FFR and PET MBF suggests that noninvasive testing with PET is useful to guide revascularization in individual patients with stable CAD because of FFR's proven prognostic value. 3, 5 Using PET imaging, however, it is not possible to allocate mendable culprit lesions like with FFR, as it does not distinguish focal epicardial from diffuse and smallvessel disease. In that respect, FFR remains a vital part of revascularization therapy to document a significant hyperemic pressure drop across a lesion and establish a likely beneficial outcome of PCI. Therefore, PET can act a noninvasive gatekeeper for invasive coronary angiography, whereas additional FFR measurements are required to drive revascularization strategy.
Furthermore, several studies have shown the prognostic value of quantitative PET, [25] [26] [27] but specific data about the prognostic value of quantitative PET after revascularization are still lacking. Yet, PET-derived information explaining the net impact of revascularization on epicardial and small vessel disease beholds a great potential for prognostic purposes.
MBF After PCI Compared With CABG
Another finding from the present study is the superior flow restoration after successful PCI as compared with CABG. It should be noted, however, that the patients undergoing bypass grafting had a more advanced stage of CAD as also documented by the increased CT-derived calcium burden in comparison with the percutaneous revascularization group. As a consequence, bypass grafting should probably not be considered an inferior revascularization strategy over coronary stenting. These results merely suggest that successful revascularization of more diffuse CAD has attenuated impact on restoration of stress perfusion as supposed to treatment of more focal disease. Of interest, among 18 patients referred for CABG, 4 were incompletely revascularized because of coronary arteries that were too small or diffusely calcified to graft. Corresponding perfusion territories were excluded from the current analysis, which further obscured residual ischemia after surgical revascularization. Furthermore, 6 vessels were refrained from grafting as they were nonstenotic.
Effect of Coronary Risk Factors on Restoration of MBF
Successful revascularization and augmentation of perfusion is not only dependent on epicardial atherosclerosis but also on microvascular health. Several reports clearly demonstrate that coronary risk factors such as diabetes mellitus, hypertension, aging, and hypercho- lesterolemia are associated with increased microvascular resistance, which could potentially limit the effect of treatment of the epicardial conduit artery. 14, [28] [29] [30] Therefore, it was hypothesized that traditional cardiovascular risk factors, as surrogate markers for microvascular disease, could be related to restoration of stress MBF and CFR. Conversely, apart from current smoking status at baseline, none of these factors seem to be related to the outcome of coronary revascularization. One might postulate that cessation of smoking after revascularization affects perfusion at follow-up. [31] [32] [33] However, smoking status at follow-up was lacking, making it hypothesis generating at most. Among cardiovascular risk factors as possible predictors for CFR improvement, diabetes mellitus showed a significant interaction at an univariable level but did not remain an independent predictor in a multivariable analysis (P=0.159). This may be attributed to an auto-regulatory increase in resting perfusion and a consequential decrease in CFR as a result of elevated resting heart rates because of diabetic dysautonomia. 34 The lack of impact of diabetic status on hyperemic perfusion supports this line of reasoning, despite its potential effect on microvascular health. It is important to realize that the vast majority of revascularization was driven by FFR in the current study, which may have introduced a bias as severe microvascular disease is less likely in patients with a significant pressure drop over an epicardial lesion because of a preserved vasodilator response of the microvascular bed. Moreover, it was hypothesized that intensification of medical therapy such as statins might impact the restoration of quantitative perfusion. 35 Although an interaction was observed for various medical treatment intensifications univariably, none did independently predict improvement of quantitative perfusion. 
Limitations
Some limitations should be acknowledged. First, the relatively short mean time interval between revascularization and follow-up PET (PCI 24 days and CABG 66 days) could have possibly mitigated the potential impact on MBF improvement. Uren et al reported a gradual increase of perfusion after angioplasty at 1-week and 3-month follow-up. 22 For CABG, recovery of perfusion has been documented to take as much as 6 months. 36 Furthermore, the difference between both follow-up intervals could have an impact on the results. Second, sample size was too small to draw definite conclusions, and therefore, more studies are warranted in larger populations, especially in the search for predictors of restoration. In addition, the current study cohort had a relatively low frequency of cardiovascular risk factors known to affect coronary microvascular function. It is, therefore, uncertain that present data can be generalized to a more comorbid population with more diabetes mellitus, metabolic syndrome, and obesity. Third, it should be acknowledged that reduced flow as assessed with PET is the result of an admixture of normal and abnormal vessels in a specific vascular territory. This combination makes it difficult to compare a specific vessel FFR to a vascular territory PET flow measure in the presence of normal and abnormal vessels.
Conclusion
Successful coronary revascularization had a positive impact on absolute myocardial perfusion as assessed by serial quantitative [
15 O]H 2 O PET imaging. Improvement of invasive FFR directly after PCI was paralleled by a concomitant increase in MBF. Therefore, PET perfusion imaging could be useful to identify patients who might benefit from revascularization. Traditional cardiovascular risk factors did not evidently predict restoration of myocardial perfusion, while PCI resulted in a greater improvement than CABG, although patients undergoing bypass grafting had a more advanced stage of CAD.
